| VRTX | Vertex Pharmaceuticals Inc | $110.74B | +62879.46% |
| VRNA | Verona Pharma Plc | $77.75B | +44115.38% |
| REGN | Regeneron Pharmaceuticals Inc | $62.57B | +35484.82% |
| ARGX | Argen X SE | $57.07B | +32358.15% |
| ALNY | Alnylam Pharmaceuticals Inc | $38.55B | +21823.91% |
| ONC | BeiGene Ltd | $30.52B | +17256.03% |
| RVMD | Revolution Medicines Inc | $28.86B | +16314.98% |
| RPRX | Royalty Pharma plc - Class A | $23.81B | +13443.04% |
| BNTX | BioNTech SE | $21.79B | +12289.81% |
| INCY | Incyte Corp | $21.07B | +11884.08% |
| ROIV | Roivant Sciences Ltd | $20.47B | +11538.68% |
| INSM | Insmed Inc | $19.89B | +11213.84% |
| MRNA | Moderna Inc | $18.26B | +10283.44% |
| GMAB | Genmab | $15.64B | +8793.53% |
| JAZZ | Jazz Pharmaceuticals plc | $14.21B | +7983.64% |
| ASND | Ascendis Pharma A/S | $13.54B | +7598.03% |
| EXEL | Exelixis Inc | $13.34B | +7486.30% |
| BBIO | BridgeBio Pharma Inc | $13.19B | +7402.18% |
| AXSM | Axsome Therapeutics Inc | $12.67B | +7103.74% |
| IONS | Ionis Pharmaceuticals Inc | $12.16B | +6817.70% |
| MDGL | Madrigal Pharmaceuticals Inc | $10.86B | +6076.21% |
| BMRN | Biomarin Pharmaceutical Inc | $10.86B | +6073.82% |
| SMMT | Summit Therapeutics Inc | $10.13B | +5659.30% |
| ARWR | Arrowhead Pharmaceuticals Inc | $9.94B | +5554.40% |
| NUVL | Nuvalent Inc - Class A | $9.70B | +5418.71% |
| KRYS | Krystal Biotech Inc | $9.20B | +5130.05% |
| HALO | Halozyme Therapeutics Inc | $8.36B | +4652.03% |
| CYTK | Cytokinetics Inc | $8.27B | +4602.01% |
| TECH | Bio-Techne Corp | $8.22B | +4573.11% |
| CORT | Corcept Therapeutics Inc | $8.16B | +4539.76% |
| ABVX | Abivax | $7.77B | +4320.50% |
| MTSR | Metsera Inc | $7.40B | +4111.06% |
| IBRX | ImmunityBio Inc | $7.31B | +4057.49% |
| TGTX | TG Therapeutics Inc | $7.14B | +3958.99% |
| MRUS | Merus N.V | $6.83B | +3781.80% |
| PTGX | Protagonist Therapeutics Inc | $6.79B | +3763.39% |
| PRAX | Praxis Precision Medicines Inc | $6.70B | +3712.98% |
| ACLX | Arcellx Inc | $6.67B | +3690.95% |
| PCVX | Vaxcyte Inc | $6.55B | +3627.74% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +3593.33% |
| LEGN | Legend Biotech Corp | $6.44B | +3562.35% |
| KYMR | Kymera Therapeutics Inc | $6.43B | +3556.27% |
| IMVT | Immunovant Inc | $6.36B | +3516.32% |
| APGE | Apogee Therapeutics Inc | $6.19B | +3422.72% |
| CNTA | Centessa Pharmaceuticals plc | $6.14B | +3392.53% |
| PTCT | PTC Therapeutics Inc | $6.08B | +3357.39% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +3282.43% |
| SYRE | Spyre Therapeutics Inc | $5.92B | +3266.34% |
| RYTM | Rhythm Pharmaceuticals Inc | $5.87B | +3236.27% |
| MIRM | Mirum Pharmaceuticals Inc | $5.73B | +3157.01% |
| BLTE | Belite Bio Inc | $5.37B | +2956.58% |
| COGT | Cogent Biosciences Inc | $5.36B | +2947.63% |
| SRRK | Scholar Rock Holding Corp | $5.25B | +2886.44% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +2884.95% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.97B | +2727.60% |
| XENE | Xenon Pharmaceuticals Inc | $4.96B | +2721.17% |
| CAI | Caris Life Sciences Inc - Class A | $4.85B | +2658.38% |
| CGON | Cg Oncology Inc | $4.83B | +2648.77% |
| CRSP | CRISPR Therapeutics AG | $4.77B | +2610.05% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +2461.61% |
| AKRO | Akero Therapeutics Inc | $4.38B | +2391.02% |
| TVTX | Travere Therapeutics Inc | $4.32B | +2356.21% |
| CELC | Celcuity Inc | $4.27B | +2326.20% |
| DNTH | Dianthus Therapeutics Inc | $4.17B | +2272.19% |
| ERAS | Erasca Inc | $4.16B | +2263.25% |
| TNGX | Tango Therapeutics Inc | $4.13B | +2251.36% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +2077.67% |
| ACAD | Acadia Pharmaceuticals Inc | $3.64B | +1967.58% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.61B | +1955.52% |
| EWTX | Edgewise Therapeutics Inc | $3.54B | +1912.25% |
| NAMS | NewAmsterdam Pharma Company NV | $3.42B | +1845.60% |
| DNLI | Denali Therapeutics Inc | $3.27B | +1759.61% |
| VKTX | Viking Therapeutics Inc | $3.22B | +1728.99% |
| ORKA | ARCA biopharma Inc | $3.21B | +1726.81% |
| TLX | Telix Pharmaceuticals Ltd | $3.20B | +1718.76% |
| BEAM | Beam Therapeutics Inc | $3.03B | +1623.10% |
| GPCR | Structure Therapeutics Inc | $2.95B | +1578.54% |
| DYN | Dyne Therapeutics Inc | $2.92B | +1560.11% |
| ARQT | Arcutis Biotherapeutics Inc | $2.90B | +1551.93% |
| RCUS | Arcus Biosciences Inc | $2.78B | +1478.76% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +1459.15% |
| TARS | Tarsus Pharmaceuticals Inc | $2.64B | +1399.06% |
| IRON | Disc Medicine Inc | $2.57B | +1360.61% |
| RLAY | Relay Therapeutics Inc | $2.55B | +1351.58% |
| ALMS | Alumis Inc | $2.51B | +1326.61% |
| IDYA | Ideaya Biosciences Inc | $2.42B | +1279.01% |
| ETNB | 89bio Inc | $2.34B | +1232.44% |
| VERA | Vera Therapeutics Inc - Class A | $2.26B | +1185.33% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.26B | +1184.11% |
| ELVN | Enliven Therapeutics Inc | $2.25B | +1181.25% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +1160.94% |
| MLYS | Mineralys Therapeutics Inc | $2.12B | +1103.21% |
| PHVS | Pharvaris NV | $2.06B | +1070.26% |
| IMNM | Immunome Inc | $2.06B | +1068.80% |
| HRMY | Harmony Biosciences Holdings Inc | $2.05B | +1067.63% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.05B | +1064.64% |
| MESO | Mesoblast Ltd | $2.02B | +1047.74% |
| ADMA | Adma Biologics Inc | $1.97B | +1020.24% |
| CLDX | Celldex Therapeutics Inc | $1.95B | +1011.14% |
| KOD | Kodiak Sciences Inc | $1.95B | +1010.29% |
| ZLAB | Zai Lab Ltd | $1.92B | +989.79% |
| OCUL | Ocular Therapeutix Inc | $1.91B | +988.02% |
| VCEL | Vericel Corp | $1.91B | +984.38% |
| GLPG | Galapagos NV | $1.90B | +979.56% |
| STOK | Stoke Therapeutics Inc | $1.77B | +908.09% |
| TRVI | Trevi Therapeutics Inc | $1.72B | +878.58% |
| AGIO | Agios Pharmaceuticals Inc | $1.71B | +874.63% |
| INVA | Innoviva Inc | $1.70B | +865.43% |
| QURE | uniQure N.V. | $1.69B | +861.43% |
| RAPP | Rapport Therapeutics Inc | $1.68B | +857.30% |
| ZYME | Zymeworks BC Inc | $1.67B | +849.96% |
| BHVN | Biohaven Ltd | $1.67B | +847.52% |
| IOVA | Iovance Biotherapeutics Inc | $1.66B | +841.80% |
| VRDN | Viridian Therapeutics Inc | $1.62B | +818.89% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.61B | +817.39% |
| NBTX | Nanobiotix | $1.60B | +812.40% |
| SRPT | Sarepta Therapeutics Inc | $1.60B | +807.19% |
| NUVB | Nuvation Bio Inc - Class A | $1.59B | +802.53% |
| NRIX | Nurix Therapeutics Inc | $1.58B | +799.70% |
| AAPG | Ascentage Pharma Group International | $1.58B | +798.97% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +789.68% |
| SNDX | Syndax Pharmaceuticals Inc | $1.56B | +785.25% |
| TSHA | Taysha Gene Therapies Inc | $1.55B | +782.23% |
| ABCL | AbCellera Biologics Inc | $1.55B | +779.83% |
| FTRE | Fortrea Holdings Inc | $1.55B | +779.08% |
| SION | Sionna Therapeutics Inc | $1.53B | +772.35% |
| ANAB | AnaptysBio Inc | $1.51B | +760.17% |
| TYRA | Tyra Biosciences Inc | $1.51B | +759.72% |
| MBX | MBX Biosciences Inc | $1.47B | +738.39% |
| NTLA | Intellia Therapeutics Inc | $1.47B | +735.69% |
| PVLA | Palvella Therapeutics Inc | $1.46B | +731.85% |
| CAPR | Capricor Therapeutics Inc | $1.46B | +730.68% |
| IMCR | Immunocore Holdings plc | $1.42B | +706.54% |
| NVAX | Novavax Inc | $1.41B | +700.43% |
| NKTR | Nektar Therapeutics | $1.40B | +698.75% |
| GLUE | Monte Rosa Therapeutics Inc | $1.39B | +692.20% |
| ARDX | Ardelyx Inc | $1.39B | +687.95% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +686.75% |
| ATAI | ATAI Life Sciences N.V. | $1.38B | +685.85% |
| AVBP | ArriVent BioPharma Inc | $1.38B | +685.65% |
| PGEN | Precigen Inc | $1.37B | +680.33% |
| SEPN | Septerna Inc | $1.37B | +678.33% |
| URGN | UroGen Pharma Ltd | $1.36B | +675.62% |
| VIR | Vir Biotechnology Inc | $1.33B | +656.48% |
| BCAX | Bicara Therapeutics Inc | $1.32B | +653.37% |
| INBX | Inhibrx Biosciences Inc | $1.31B | +643.25% |
| SLS | SELLAS Life Sciences Group Inc | $1.30B | +637.34% |
| GHRS | GH Research PLC | $1.26B | +618.28% |
| MPLT | MapLight Therapeutics Inc | $1.26B | +614.75% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.25B | +608.93% |
| TRML | Tourmaline Bio Inc | $1.24B | +602.76% |
| IMTX | Immatics N.V | $1.19B | +579.21% |
| MAZE | Maze Therapeutics Inc | $1.18B | +569.25% |
| MNKD | Mannkind Corp | $1.12B | +537.71% |
| ZBIO | Zenas Biopharma Inc | $1.12B | +535.41% |
| WVE | Wave Life Sciences Ltd | $1.09B | +519.11% |
| CVAC | CureVac N.V. | $1.05B | +496.75% |
| SVRA | Savara Inc | $1.04B | +493.19% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.03B | +485.18% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +467.98% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +462.94% |
| ABSI | Absci Corp | $975.90M | +455.00% |
| DBVT | DBV Technologies | $949.70M | +440.10% |
| CRVS | Corvus Pharmaceuticals Inc | $938.45M | +433.70% |
| SPRY | ARS Pharmaceuticals Inc | $919.52M | +422.94% |
| ANNX | Annexon Inc | $916.62M | +421.29% |
| XNCR | Xencor Inc | $876.18M | +398.29% |
| PHAR | Pharming Group N.V. | $861.32M | +389.84% |
| OLMA | Olema Pharmaceuticals Inc | $857.61M | +387.73% |
| TBPH | Theravance Biopharma Inc | $843.30M | +379.59% |
| LBRX | LB Pharmaceuticals Inc | $814.08M | +362.97% |
| DRTS | Alpha Tau Medical Ltd | $813.21M | +362.48% |
| ABUS | Arbutus Biopharma Corp | $811.42M | +361.46% |
| JANX | Janux Therapeutics Inc | $800.38M | +355.18% |
| LXRX | Lexicon Pharmaceuticals Inc | $800.33M | +355.15% |
| ZVRA | Zevra Therapeutics Inc | $798.05M | +353.86% |
| ORIC | ORIC Pharmaceuticals Inc | $780.29M | +343.75% |
| PHAT | Phathom Pharmaceuticals Inc | $780.12M | +343.66% |
| KURA | Kura Oncology Inc | $770.46M | +338.17% |
| CMRX | Chimerix Inc | $766.03M | +335.65% |
| SANA | Sana Biotechnology Inc | $760.88M | +332.72% |
| JBIO | Jade Biosciences Inc | $753.02M | +328.25% |
| MGTX | MeiraGTx Holdings plc | $744.42M | +323.35% |
| CGEM | Cullinan Oncology Inc | $740.49M | +321.12% |
| EVMN | Evommune Inc | $738.02M | +319.71% |
| GERN | Geron Corp | $736.31M | +318.75% |
| OMER | Omeros Corporation | $734.39M | +317.65% |
| ATXS | Astria Therapeutics Inc | $709.95M | +303.75% |
| VOR | Vor Biopharma Inc | $704.41M | +300.60% |
| ANRO | Alto Neuroscience Inc | $689.84M | +292.31% |
| CRMD | CorMedix Inc | $687.53M | +291.00% |
| REPL | Replimune Group Inc | $674.48M | +283.58% |
| RLMD | Relmada Therapeutics Inc | $669.20M | +280.58% |
| DSGN | Design Therapeutics Inc | $665.63M | +278.54% |
| IVA | Inventiva | $655.21M | +272.62% |
| SLDB | Solid Biosciences Inc | $650.39M | +269.88% |
| OCS | Oculis Holding AG | $646.19M | +267.49% |
| CADL | Candel Therapeutics Inc | $611.70M | +247.88% |
| DRUG | Bright Minds Biosciences Inc | $590.35M | +235.74% |
| ACRS | Aclaris Therapeutics Inc | $572.58M | +225.63% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $570.23M | +224.29% |
| RIGL | Rigel Pharmaceuticals | $569.11M | +223.66% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +213.26% |
| GYRE | Gyre Therapeutics Inc | $543.46M | +209.07% |
| MDXG | Mimedx Group Inc | $542.11M | +208.30% |
| TECX | AvroBio Inc | $528.19M | +200.39% |
| CLYM | Eliem Therapeutics Inc | $515.90M | +193.40% |
| CTMX | CytomX Therapeutics Inc | $515.86M | +193.37% |
| CABA | Cabaletta Bio Inc | $508.29M | +189.07% |
| XOMA | XOMA Corp | $497.36M | +182.85% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $489.59M | +178.43% |
| PRME | Prime Medicine Inc | $489.47M | +178.36% |
| CBIO | N/A | $484.44M | +175.50% |
| SVA | Sinovac Biotech Ltd | $464.94M | +164.41% |
| KYTX | Kyverna Therapeutics Inc | $463.68M | +163.70% |
| FDMT | 4D Molecular Therapeutics Inc | $455.81M | +159.22% |
| VALN | Valneva SE | $452.59M | +157.39% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +156.72% |
| ARVN | Arvinas Inc | $450.21M | +156.04% |
| NGNE | Neoleukin Therapeutics Inc | $437.40M | +148.75% |
| IMMX | Immix Biopharma Inc | $433.64M | +146.61% |
| STRO | Sutro Biopharma Inc | $432.23M | +145.81% |
| AURA | Aura Biosciences Inc | $430.49M | +144.82% |
| CTNM | Contineum Therapeutics Inc - Class A | $421.93M | +139.95% |
| PRTA | Prothena Corporation plc | $419.84M | +138.77% |
| CYBN | Cybin Inc | $408.43M | +132.28% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +129.62% |
| CCCC | C4 Therapeutics Inc | $402.62M | +128.97% |
| OCGN | Ocugen Inc | $402.60M | +128.96% |
| MNPR | Monopar Therapeutics Inc | $398.06M | +126.38% |
| AUTL | Autolus Therapeutics plc | $393.89M | +124.01% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +121.90% |
| IPSC | Century Therapeutics Inc | $381.82M | +117.14% |
| OVID | Ovid Therapeutics Inc | $381.37M | +116.89% |
| RVNC | Revance Therapeutics Inc | $380.38M | +116.32% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +114.39% |
| ALT | Altimmune Inc | $373.67M | +112.51% |
| RZLT | Rezolute Inc | $366.87M | +108.64% |
| VNDA | Vanda Pharmaceuticals Inc | $362.61M | +106.22% |
| UPB | Upstream Bio Inc | $358.50M | +103.88% |
| LRMR | Larimar Therapeutics Inc | $357.36M | +103.23% |
| PBYI | Puma Biotechnology Inc | $357.17M | +103.13% |
| BNTC | Benitec Biopharma Inc | $356.94M | +102.99% |
| ASMB | Assembly Biosciences Inc | $353.76M | +101.19% |
| XFOR | X4 Pharmaceuticals Inc | $351.81M | +100.08% |
| AVIR | Atea Pharmaceuticals Inc | $351.32M | +99.80% |
| EDIT | Editas Medicine Inc | $349.39M | +98.70% |
| CMPX | Compass Therapeutics Inc | $345.77M | +96.64% |
| OABI | OmniAb Inc | $344.59M | +95.97% |
| FBRX | Forte Biosciences Inc | $340.15M | +93.45% |
| ENTA | Enanta Pharmaceuticals Inc | $340.01M | +93.37% |
| IMAB | I-Mab | $339.64M | +93.15% |
| ZURA | Zura Bio Ltd - Class A | $336.83M | +91.56% |
| VSTM | Verastem Inc | $330.29M | +87.84% |
| PRLD | Prelude Therapeutics Inc | $325.95M | +85.37% |
| GLSI | Greenwich LifeSciences Inc | $324.27M | +84.41% |
| CLLS | Cellectis | $319.68M | +81.80% |
| ANL | Adlai Nortye Ltd | $317.46M | +80.54% |
| RGNX | Regenxbio Inc | $316.41M | +79.95% |
| STTK | Shattuck Labs Inc | $312.15M | +77.52% |
| LYEL | Lyell Immunopharma Inc | $308.40M | +75.39% |
| EPRX | Eupraxia Pharmaceuticals Inc | $307.48M | +74.87% |
| LCTX | Lineage Cell Therapeutics Inc | $306.64M | +74.39% |
| LXEO | Lexeo Therapeutics Inc | $305.98M | +74.01% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +73.49% |
| ABEO | Abeona Therapeutics Inc | $304.80M | +73.34% |
| SCPH | scPharmaceuticals Inc | $304.59M | +73.22% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +72.24% |
| FENC | Fennec Pharmaceuticals Inc | $300.51M | +70.90% |
| HUMA | Humacyte Inc | $297.51M | +69.19% |
| NMRA | Neumora Therapeutics Inc | $287.80M | +63.67% |
| DMAC | DiaMedica Therapeutics Inc | $287.20M | +63.33% |
| NAUT | Nautilus Biotechnology Inc | $287.18M | +63.32% |
| RCKT | Rocket Pharmaceuticals Inc | $283.72M | +61.35% |
| SLN | Silence Therapeutics Plc | $283.41M | +61.18% |
| PALI | Palisade Bio Inc | $281.27M | +59.96% |
| BCYC | Bicycle Therapeutics Plc | $280.92M | +59.76% |
| IRD | Ocuphire Pharma Inc | $277.76M | +57.96% |
| INDP | Indaptus Therapeutics Inc | $277.44M | +57.78% |
| ARMP | Armata Pharmaceuticals Inc | $276.17M | +57.06% |
| NAGE | Niagen Bioscience Inc | $275.72M | +56.80% |
| NVCT | Nuvectis Pharma Inc | $273.48M | +55.53% |
| ELTX | Elicio Therapeutics Inc | $266.55M | +51.59% |
| ELDN | Eledon Pharmaceuticals Inc | $262.45M | +49.26% |
| ZNTL | Zentalis Pharmaceuticals Inc | $256.16M | +45.68% |
| TENX | Tenax Therapeutics Inc | $256.11M | +45.65% |
| IVVD | Invivyd Inc | $254.78M | +44.89% |
| IMRX | Immuneering Corp Class A | $253.46M | +44.15% |
| SABS | SAB Biotherapeutics Inc | $250.71M | +42.58% |
| SRZN | Surrozen Inc | $250.14M | +42.25% |
| MGNX | Macrogenics Inc | $245.98M | +39.89% |
| THRD | Third Harmonic Bio Inc | $241.86M | +37.55% |
| OBIO | Orchestra BioMed Holdings Inc | $235.70M | +34.04% |
| FULC | Fulcrum Therapeutics Inc | $233.79M | +32.96% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +32.52% |
| TRDA | Entrada Therapeutics Inc | $231.76M | +31.80% |
| SLRN | Acelyrin Inc | $228.54M | +29.97% |
| AVXL | Anavex Life Sciences Corporation | $227.97M | +29.65% |
| FHTX | Foghorn Therapeutics Inc | $226.04M | +28.55% |
| CAMP | CAMP4 Therapeutics Corp | $225.36M | +28.16% |
| YDES | YD Bio Ltd | $219.80M | +25.00% |
| IKT | Inhibikase Therapeutics Inc | $219.17M | +24.65% |
| FATE | Fate Therapeutics Inc | $217.43M | +23.65% |
| CDXS | Codexis Inc | $213.60M | +21.48% |
| RNAC | Cartesian Therapeutics Inc | $212.09M | +20.62% |
| CHRS | Coherus Biosciences Inc | $209.74M | +19.28% |
| ACIU | AC Immune SA | $209.19M | +18.97% |
| TARA | Protara Therapeutics Inc | $208.11M | +18.35% |
| LENZ | LENZ Therapeutics Inc | $206.31M | +17.33% |
| KPTI | Karyopharm Therapeutics Inc | $205.38M | +16.80% |
| SLGL | Sol-Gel Technologies Ltd | $204.76M | +16.45% |
| NERV | Minerva Neurosciences Inc | $204.74M | +16.44% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +14.77% |
| VYGR | Voyager Therapeutics Inc | $200.23M | +13.87% |
| RNA | Atrium Therapeutics Inc | $199.62M | +13.53% |
| ADAG | Adagene Inc | $196.65M | +11.84% |
| ALXO | Alx Oncology Holdings Inc | $196.43M | +11.71% |
| KROS | Keros Therapeutics Inc | $195.95M | +11.44% |
| ARCT | Arcturus Therapeutics Holdings Inc | $195.83M | +11.37% |
| UNCY | Unicycive Therapeutics Inc | $194.08M | +10.37% |
| WHWK | Whitehawk Therapeutics Inc | $189.73M | +7.90% |
| QTTB | Q32 Bio Inc | $188.28M | +7.08% |
| CGEN | Compugen Ltd | $185.32M | +5.39% |
| NKTX | Nkarta Inc | $182.67M | +3.89% |
| IFRX | InflaRx N.V. | $182.18M | +3.61% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +2.83% |
| MDWD | MediWound Ltd | $178.43M | +1.48% |
| ACHV | Achieve Life Sciences Inc | $173.54M | -1.31% |
| CRBU | Caribou Biosciences Inc | $173.54M | -1.31% |
| EQ | Equillium Inc | $168.81M | -3.99% |
| ALEC | Alector Inc | $168.76M | -4.03% |
| THTX | Theratechnologies Inc | $167.34M | -4.83% |
| THAR | Tharimmune Inc | $167.14M | -4.95% |
| DTIL | Precision Biosciences Inc | $166.45M | -5.34% |
| TTRX | Turn Therapeutics Inc | $164.73M | -6.32% |
| ABOS | Acumen Pharmaceuticals Inc | $161.79M | -7.99% |
| IPHA | Innate Pharma | $159.97M | -9.02% |
| ENLV | Enlivex Therapeutics Ltd | $159.66M | -9.20% |
| IMUX | Immunic Inc | $159.51M | -9.29% |
| PLX | Protalix BioTherapeutics Inc | $157.30M | -10.54% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $155.69M | -11.46% |
| KRRO | Korro Bio Inc | $152.74M | -13.14% |
| TNYA | Tenaya Therapeutics Inc | $151.53M | -13.82% |
| ORMP | Oramed Pharmaceuticals Inc | $151.43M | -13.88% |
| ANTX | AN2 Therapeutics Inc | $151.14M | -14.05% |
| NBP | NovaBridge Biosciences. | $150.91M | -14.18% |
| PRQR | ProQR Therapeutics N.V | $148.56M | -15.51% |
| AKTX | Akari Therapeutics Plc | $148.12M | -15.76% |
| SPRO | Spero Therapeutics Inc | $147.04M | -16.38% |
| MRSN | Mersana Therapeutics Inc | $145.36M | -17.34% |
| MIST | Milestone Pharmaceuticals Inc | $143.71M | -18.27% |
| VXRT | Vaxart Inc | $142.43M | -19.00% |
| RANI | Rani Therapeutics Holdings Inc Class A | $140.94M | -19.85% |
| ADCT | Adc Therapeutics SA | $139.88M | -20.45% |
| MOLN | Molecular Partners AG | $139.51M | -20.66% |
| PROK | ProKidney Corp - Class A | $137.85M | -21.60% |
| TCRX | Tscan Therapeutics Inc | $137.63M | -21.73% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $136.59M | -22.32% |
| CNTX | Context Therapeutics Inc | $133.22M | -24.23% |
| HURA | TuHURA Biosciences Inc | $132.24M | -24.79% |
| MENS | Jyong Biotech Ltd | $130.77M | -25.63% |
| CNTB | Connect Biopharma Holdings Ltd | $130.44M | -25.82% |
| ACOG | Alpha Cognition Inc | $130.43M | -25.83% |
| GNLX | Genelux Corp | $128.24M | -27.07% |
| NRXP | NRX Pharmaceuticals Inc | $125.85M | -28.43% |
| AGEN | Agenus Inc | $118.26M | -32.74% |
| GUTS | Fractyl Health Inc | $116.10M | -33.97% |
| SAVA | Cassava Sciences Inc. | $114.97M | -34.61% |
| RPTX | Repare Therapeutics Inc | $113.91M | -35.22% |
| NTHI | NeOnc Technologies Holdings Inc | $112.95M | -35.76% |
| ENGN | enGene Holdings Inc | $107.18M | -39.04% |
| BDTX | Black Diamond Therapeutics Inc | $106.01M | -39.71% |
| PYXS | Pyxis Oncology Inc | $104.93M | -40.33% |
| HLVX | HilleVax Inc | $104.74M | -40.43% |
| COYA | Coya Therapeutics Inc | $103.45M | -41.17% |
| SEER | Seer Inc - Class A | $103.40M | -41.19% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | -41.76% |
| ALDX | Aldeyra Therapeutics Inc | $101.94M | -42.02% |
| CGTX | Cognition Therapeutics Inc | $101.86M | -42.07% |
| CRDF | Cardiff Oncology Inc | $101.19M | -42.45% |
| VRCA | Verrica Pharmaceuticals Inc | $98.78M | -43.82% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | -44.41% |
| PEPG | PepGen Inc | $97.09M | -44.78% |
| VANI | Vivani Medical Inc | $95.65M | -45.60% |
| KLRS | Kalaris Therapeutics Inc | $95.65M | -45.60% |
| OTLK | Outlook Therapeutics Inc | $93.11M | -47.05% |
| ONCY | Oncolytics Biotech Inc | $92.91M | -47.16% |
| PTHS | Channel Therapeutics Corporation | $92.40M | -47.45% |
| FBIO | Fortress Biotech Inc | $91.93M | -47.72% |
| PMN | ProMIS Neurosciences Inc | $91.47M | -47.98% |
| CUE | Cue Biopharma Inc | $90.69M | -48.42% |
| ICCC | Immucell Corp | $87.48M | -50.25% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | -50.53% |
| LPTX | Leap Therapeutics Inc | $84.76M | -51.80% |
| RLYB | Rallybio Corp | $84.33M | -52.04% |
| ATRA | Atara Biotherapeutics Inc | $83.93M | -52.27% |
| BMEA | Biomea Fusion Inc | $83.14M | -52.72% |
| PYPD | Polypid Ltd | $82.10M | -53.31% |
| CSBR | Champions Oncology Inc | $79.43M | -54.83% |
| ANIX | Anixa Biosciences Inc | $78.64M | -55.28% |
| CBUS | Cibus Global Ltd. Class A | $78.24M | -55.50% |
| NRXS | Neuraxis Inc | $77.86M | -55.72% |
| FBIOP | Fortress Biotech Inc | $77.72M | -55.80% |
| HRTX | Heron Therapeutics Inc | $77.45M | -55.95% |
| ATHA | Athira Pharma Inc | $77.21M | -56.09% |
| MAIA | MAIA Biotechnology Inc | $77.05M | -56.18% |
| INO | Inovio Pharmaceuticals Inc | $76.05M | -56.75% |
| AARD | Aardvark Therapeutics Inc | $75.92M | -56.82% |
| HYFT | MindWalk Holdings Corp | $74.89M | -57.41% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | -57.53% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | -59.10% |
| PLRX | Pliant Therapeutics Inc | $71.82M | -59.16% |
| XBIT | XBiotech Inc | $71.65M | -59.25% |
| ATHE | Alterity Therapeutics Ltd | $70.41M | -59.96% |
| ACET | Adicet Bio Inc | $70.16M | -60.10% |
| GANX | Gain Therapeutics Inc | $69.68M | -60.37% |
| SPRB | Spruce Biosciences Inc | $67.96M | -61.35% |
| BYSI | BeyondSpring Inc | $67.85M | -61.41% |
| OSTX | OS Therapies Inc | $66.38M | -62.25% |
| EXOZ | Invizyne Technologies Inc | $65.46M | -62.77% |
| IBIO | iBio Inc | $64.94M | -63.07% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | -63.86% |
| ACHL | Achilles Therapeutics Plc | $63.22M | -64.05% |
| MNOV | Medicinova Inc | $62.51M | -64.45% |
| MCRB | Seres Therapeutics Inc | $62.25M | -64.60% |
| IMA | Ikena Oncology Inc | $61.77M | -64.87% |
| IBO | Impact BioMedical Inc | $61.35M | -65.11% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | -66.33% |
| PDSB | PDS Biotechnology Corporation | $59.16M | -66.35% |
| INKT | MiNK Therapeutics Inc | $58.49M | -66.74% |
| CING | Cingulate Inc | $58.23M | -66.88% |
| SGMO | Sangamo Therapeutics Inc | $58.05M | -66.99% |
| ANVS | Annovis Bio Inc | $57.22M | -67.46% |
| PMVP | PMV Pharmaceuticals Inc | $56.53M | -67.85% |
| OKYO | OKYO Pharma Ltd - New | $55.76M | -68.29% |
| ENTX | Entera Bio Ltd | $54.55M | -68.98% |
| TIL | Instil Bio Inc | $54.12M | -69.22% |
| KZR | Kezar Life Sciences Inc | $53.76M | -69.43% |
| ACRV | Acrivon Therapeutics Inc | $53.47M | -69.59% |
| IMMP | Immutep Ltd | $52.32M | -70.25% |
| RNTX | Rein Therapeutics Inc | $51.79M | -70.54% |
| GOSS | Gossamer Bio Inc | $51.14M | -70.92% |
| DWTX | Virios Therapeutics Inc | $49.77M | -71.70% |
| MREO | Mereo Biopharma Group Plc | $48.86M | -72.21% |
| GLTO | Galecto Inc | $48.60M | -72.36% |
| VERU | Veru Inc | $47.35M | -73.07% |
| MGX | Metagenomi Inc | $46.31M | -73.67% |
| EDSA | Edesa Biotech Inc | $46.29M | -73.67% |
| ACTU | Actuate Therapeutics Inc | $46.24M | -73.70% |
| ATYR | Atyr Pharma Inc | $45.93M | -73.88% |
| LVTX | LAVA Therapeutics NV | $45.77M | -73.97% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | -73.99% |
| XLO | Xilio Therapeutics Inc | $45.68M | -74.02% |
| ESLA | Estrella Immunopharma Inc | $44.65M | -74.61% |
| KALA | Kala Bio Inc | $44.43M | -74.73% |
| TVGN | Tevogen Bio Holdings Inc | $44.19M | -74.87% |
| LTRN | Lantern Pharma Inc | $43.67M | -75.17% |
| NTRB | Nutriband Inc | $41.45M | -76.43% |
| FGEN | FibroGen Inc | $39.31M | -77.65% |
| GNTA | Genenta Science SpA | $38.66M | -78.01% |
| RNXT | RenovoRx Inc | $38.33M | -78.20% |
| ATOS | Atossa Therapeutics Inc | $37.89M | -78.45% |
| PSTV | Plus Therapeutics Inc | $36.99M | -78.97% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | -79.47% |
| GRCE | Acasti Pharma Inc | $35.75M | -79.67% |
| GRDX | Entero Therapeutics Inc | $35.37M | -79.89% |
| MURA | Mural Oncology plc | $35.34M | -79.90% |
| ABVC | ABVC BioPharma Inc | $33.24M | -81.10% |
| ATNM | Actinium Pharmaceuticals Inc | $32.94M | -81.26% |
| LSTA | Lisata Therapeutics Inc | $32.88M | -81.30% |
| INMB | INmune Bio Inc | $32.17M | -81.71% |
| ALGS | Aligos Therapeutics Inc | $31.93M | -81.84% |
| EVAX | Evaxion Biotech A/S | $31.61M | -82.02% |
| CRVO | CervoMed Inc | $31.25M | -82.23% |
| BOLD | Boundless Bio Inc | $30.92M | -82.41% |
| SNTI | Senti Biosciences Inc | $29.90M | -82.99% |
| APLM | Apollomics Inc - Class A | $29.61M | -83.16% |
| DARE | Dare Bioscience Inc | $29.12M | -83.44% |
| NNVC | NanoViricides Inc | $29.01M | -83.50% |
| HYPD | Eyenovia Inc | $28.80M | -83.62% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.33M | -83.89% |
| IGC | IGC Pharma Inc | $27.76M | -84.21% |
| SKYE | Skye Bioscience Inc | $27.40M | -84.42% |
| DYAI | Dyadic International Inc DE | $26.60M | -84.87% |
| LITS | Lite Strategy Inc | $26.17M | -85.11% |
| SER | AgeX Therapeutics Inc | $25.92M | -85.26% |
| TVRD | Cara Therapeutics Inc | $25.33M | -85.59% |
| PTN | Palatin Technologies Inc | $24.23M | -86.22% |
| MRKR | Marker Therapeutics Inc | $23.88M | -86.42% |
| NRSN | NeuroSense Therapeutics Ltd | $23.81M | -86.46% |
| NEUP | Neuphoria Therapeutics Inc | $23.77M | -86.48% |
| PLUR | Pluri Inc | $23.57M | -86.59% |
| ALLR | Allarity Therapeutics Inc | $23.57M | -86.60% |
| VTGN | VistaGen Therapeutics Inc | $22.60M | -87.15% |
| CELU | Celularity Inc - Class A | $22.31M | -87.31% |
| VYNE | VYNE Therapeutics Inc | $21.97M | -87.51% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | -87.51% |
| HOTH | Hoth Therapeutics Inc | $21.64M | -87.69% |
| OPT | Opthea Ltd | $21.53M | -87.76% |
| BCTX | BriaCell Therapeutics Corp - New | $20.88M | -88.12% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | -88.41% |
| LGVN | Longeveron Inc - Class A | $19.09M | -89.14% |
| TPST | Tempest Therapeutics Inc | $18.22M | -89.64% |
| AEON | AEON Biopharma Inc - Class A | $17.97M | -89.78% |
| PLRZ | Polyrizon Ltd | $17.79M | -89.88% |
| HOWL | Werewolf Therapeutics Inc | $17.74M | -89.91% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.64M | -89.97% |
| XCUR | Exicure Inc | $17.59M | -90.00% |
| CRIS | Curis Inc | $17.26M | -90.18% |
| PASG | Passage Bio Inc | $16.46M | -90.64% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $16.43M | -90.65% |
| LEXX | Lexaria Bioscience Corp | $16.33M | -90.72% |
| SNSE | Sensei Biotherapeutics Inc | $15.29M | -91.30% |
| HIND | ReShape Lifesciences Inc | $15.27M | -91.32% |
| NCEL | NLS Pharmaceutics Ltd | $15.21M | -91.35% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -91.49% |
| QNCX | Quince Therapeutics Inc | $14.89M | -91.53% |
| APLT | Applied Therapeutics Inc | $14.86M | -91.55% |
| LPCN | Lipocine Inc | $14.80M | -91.58% |
| CALC | CalciMedica Inc | $14.67M | -91.66% |
| GTBP | GT Biopharma Inc | $14.61M | -91.69% |
| BLRX | Bioline Rx Ltd | $14.54M | -91.73% |
| IOBT | IO Biotech Inc | $14.50M | -91.75% |
| KTTA | Pasithea Therapeutics Corp | $14.47M | -91.77% |
| HOOK | Hookipa Pharma Inc | $14.43M | -91.80% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $13.91M | -92.09% |
| COCP | Cocrystal Pharma Inc | $13.79M | -92.16% |
| INAB | IN8bio Inc | $13.79M | -92.16% |
| MBRX | Moleculin Biotech Inc | $13.34M | -92.41% |
| CYCN | Cyclerion Therapeutics Inc | $13.11M | -92.55% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -92.60% |
| JSPR | Jasper Therapeutics Inc | $13.00M | -92.61% |
| CMMB | Chemomab Therapeutics Ltd | $12.59M | -92.84% |
| GDTC | CytoMed Therapeutics Ltd | $12.56M | -92.86% |
| CTXR | Citius Pharmaceuticals Inc | $12.37M | -92.96% |
| PHIO | Phio Pharmaceuticals Corp | $12.31M | -93.00% |
| BIVI | BioVie Inc - Class A | $12.29M | -93.01% |
| AIM | AIM ImmunoTech Inc. | $12.14M | -93.10% |
| TRAW | Traws Pharma Inc | $11.70M | -93.35% |
| TOVX | Theriva Biologics Inc | $11.17M | -93.64% |
| ICU | SeaStar Medical Holding Corp | $10.50M | -94.03% |
| KPRX | Kiora Pharmaceuticals Inc | $10.50M | -94.03% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -94.07% |
| CVKD | Cadrenal Therapeutics Inc | $10.38M | -94.10% |
| CVM | Cel-Sci Corp | $10.15M | -94.23% |
| MTVA | MetaVia Inc | $10.12M | -94.24% |
| LNAI | Lunai Bioworks Inc | $10.11M | -94.25% |
| MLEC | Moolec Science SA | $10.06M | -94.28% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.92M | -94.36% |
| BCDA | BioCardia Inc | $9.85M | -94.40% |
| BRTX | BioRestorative Therapies Inc | $9.68M | -94.49% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $9.58M | -94.55% |
| INTS | Intensity Therapeutics Inc | $9.50M | -94.60% |
| CURX | Curanex Pharmaceuticals Inc | $9.25M | -94.74% |
| SYBX | Synlogic Inc | $9.24M | -94.74% |
| KAPA | Kairos Pharma Ltd | $9.21M | -94.76% |
| BCLI | Brainstorm Cell Therapeutics Inc | $9.15M | -94.79% |
| APRE | Aprea Therapeutics Inc | $9.05M | -94.86% |
| EPIX | Essa Pharma Inc | $8.93M | -94.92% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -94.93% |
| BOLT | Bolt Biotherapeutics Inc | $8.51M | -95.16% |
| ASBP | Aspire Biopharma Holdings Inc | $8.39M | -95.23% |
| JUNS | Jupiter Neurosciences Inc | $8.16M | -95.36% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -95.42% |
| NXTC | Nextcure Inc | $8.04M | -95.42% |
| IMRN | Immuron Ltd | $8.02M | -95.44% |
| CELZ | Creative Medical Technology Holdings Inc | $7.80M | -95.56% |
| IMNN | Imunon Inc | $7.77M | -95.58% |
| ADXN | Addex Therapeutics Ltd | $7.71M | -95.62% |
| PMCB | PharmaCyte Biotech Inc | $7.51M | -95.73% |
| ERNA | Ernexa Therapeutics Inc | $7.39M | -95.80% |
| CANF | Can-Fite Biopharma Ltd | $7.38M | -95.80% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -95.83% |
| NCNA | NuCana plc | $7.21M | -95.90% |
| SILO | SILO Pharma Inc | $6.94M | -96.05% |
| XBIO | Xenetic Biosciences Inc | $6.88M | -96.09% |
| APM | Aptorum Group Ltd - Class A | $6.64M | -96.22% |
| HCWB | HCW Biologics Inc | $6.57M | -96.27% |
| GOVX | Geovax Labs Inc | $6.29M | -96.43% |
| LIMN | Liminatus Pharma Inc | $6.17M | -96.49% |
| BCAB | BioAtla Inc | $6.06M | -96.56% |
| PPBT | Purple Biotech Ltd | $6.05M | -96.56% |
| EVGN | Evogene Ltd | $5.77M | -96.72% |
| GNPX | Genprex Inc | $5.75M | -96.73% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.71M | -96.75% |
| APVO | Aptevo Therapeutics Inc | $5.68M | -96.77% |
| ACXP | Acurx Pharmaceuticals Inc | $5.42M | -96.92% |
| PCSA | Processa Pharmaceuticals Inc | $5.30M | -96.98% |
| MTNB | Matinas Biopharma Holdings Inc | $5.09M | -97.10% |
| RNAZ | TransCode Therapeutics Inc | $5.05M | -97.13% |
| PULM | Pulmatrix Inc | $5.00M | -97.15% |
| BGMS | Bio Green Med Solution Inc | $4.99M | -97.16% |
| MBIO | Mustang Bio Inc | $4.96M | -97.18% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -97.21% |
| SNGX | Soligenix Inc | $4.81M | -97.26% |
| DRMA | Dermata Therapeutics Inc | $4.79M | -97.28% |
| TCRT | Alaunos Therapeutics Inc | $4.69M | -97.34% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.65M | -97.36% |
| ALZN | Alzamend Neuro Inc | $4.41M | -97.49% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -97.57% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -97.58% |
| ENVB | Enveric Biosciences Inc | $4.15M | -97.64% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -97.65% |
| REVB | Revelation Biosciences Inc | $4.03M | -97.71% |
| BDRX | Biodexa Pharmaceuticals Plc | $4.01M | -97.72% |
| AZTR | Azitra Inc | $3.85M | -97.81% |
| PBM | Psyence Biomedical Ltd | $3.76M | -97.86% |
| CMND | Clearmind Medicine Inc | $3.72M | -97.89% |
| GRI | GRI Bio Inc | $3.66M | -97.92% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.64M | -97.93% |
| FBLG | FibroBiologics Inc | $3.60M | -97.95% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.46M | -98.03% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -98.10% |
| ADIL | Adial Pharmaceuticals Inc | $3.26M | -98.15% |
| VIVS | VivoSim Labs Inc | $3.08M | -98.25% |
| SPRC | SciSparc Ltd | $3.05M | -98.27% |
| AFMD | Affimed N.V. | $2.98M | -98.31% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -98.36% |
| ARTL | Artelo Biosciences Inc | $2.75M | -98.44% |
| OGEN | Oragenics Inc | $2.59M | -98.53% |
| PPCB | Propanc Biopharma Inc | $2.50M | -98.58% |
| NBY | Stablecoin Development Corp | $2.40M | -98.63% |
| NTBL | Notable Labs Inc Ord | $2.39M | -98.64% |
| BBLG | Bone Biologics Corp | $2.23M | -98.73% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -98.78% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -98.81% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -98.87% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -99.11% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -99.14% |
| ONCO | Onconetix Inc | $1.45M | -99.18% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -99.19% |
| ZVSA | ZyVersa Therapeutics Inc | $1.42M | -99.19% |
| JAGX | Jaguar Health Inc | $1.34M | -99.24% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -99.26% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.13M | -99.36% |
| LYRA | Lyra Therapeutics Inc | $1.07M | -99.39% |
| PTIX | Protagenic Therapeutics Inc | $1.04M | -99.41% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -99.69% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -99.75% |
| ELAB | PMGC Holdings Inc | $221376.00 | -99.87% |
| CDT | CDT Equity Inc | $110551.31 | -99.94% |
| ADTX | Aditxt Inc | $98471.97 | -99.94% |